ResMed Inc. (RMD) to Distribute Quarterly Dividend of $0.66 on December 17th

ResMed Inc. (NYSE:RMD) declared a quarterly dividend on Thursday, October 29th. Shareholders of record on Thursday, November 12th will be paid a dividend of $0.66 per share by the medical equipment provider on Thursday, December 17th. This represents a $2.64 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Thursday, November 12th.

ResMed has raised its dividend payment by an average of 0.1% per year over the last three years and has increased its dividend annually for the last 13 consecutive years. ResMed has a payout ratio of 25.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect ResMed to earn $13.19 per share next year, which means the company should continue to be able to cover its $2.64 annual dividend with an expected future payout ratio of 20.0%.

ResMed Stock Performance

Shares of RMD stock opened at $230.76 on Friday. The firm has a 50 day moving average of $231.87 and a 200-day moving average of $225.43. The company has a market cap of $32.45 billion, a price-to-earnings ratio of 21.02, a price-to-earnings-growth ratio of 1.55 and a beta of 0.75. The company has a quick ratio of 2.42, a current ratio of 3.10 and a debt-to-equity ratio of 0.06. ResMed has a 52 week low of $180.26 and a 52 week high of $277.67.

ResMed (NYSE:RMD) last released its earnings results on Thursday, October 29th. The medical equipment provider reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.67 by $0.24. The company had revenue of $1.41 billion for the quarter, compared to the consensus estimate of $1.39 billion. ResMed had a net margin of 27.79% and a return on equity of 25.90%. ResMed’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.55 EPS. On average, equities analysts forecast that ResMed will post 12.11 earnings per share for the current year.

Key Stories Impacting ResMed

Here are the key news stories impacting ResMed this week:

• Positive Sentiment: Quarterly results exceeded expectations. ResMed reported fiscal Q1 2027 adjusted earnings of $2.91 per share versus the $2.67 consensus estimate, while revenue rose 5.9% year over year to $1.41 billion, ahead of the $1.39 billion forecast. ResMed fiscal first-quarter results
• Positive Sentiment: Profitability and demand trends improved. Sustained demand for sleep devices, productivity gains and gross-margin expansion supported the earnings beat. EPS increased from $2.55 in the year-ago quarter, and ResMed reported a 26.94% net margin. ResMed earnings and margin growth
• Positive Sentiment: Analysts raised price targets. RBC increased its target from $262 to $288 and assigned an “outperform” rating. KeyCorp raised its target from $267 to $277 with an “overweight” rating, while Wells Fargo lifted its target from $215 to $250 and maintained “equal weight.” Citigroup raised its target from $240 to $270 but retained a “neutral” rating. Analyst target changes
• Neutral Sentiment: ResMed declared a quarterly dividend of $0.66 per share, or $2.64 annualized, representing an approximately 1.1% yield. The dividend supports shareholder returns but is unlikely to be the primary near-term stock catalyst.
• Negative Sentiment: Full-year guidance was unchanged. The lack of an outlook increase may have disappointed investors who expected the earnings beat and improving margins to result in raised expectations. The neutral ratings from Citigroup and Wells Fargo may also limit the impact of the higher price targets. ResMed maintains prior guidance

ResMed Company Profile

ResMed Inc is a medical equipment and software company that develops solutions for sleep-disordered breathing, respiratory conditions and other chronic diseases. The company is best known for its positive airway pressure (PAP) devices used to treat obstructive sleep apnea, along with masks, accessories and related patient support services.

ResMed also provides cloud-connected health technology, including remote-monitoring platforms and software used by healthcare providers, medical equipment suppliers and care organizations.